New report finds huge variation in the use of modern drugs to help safeguard heart rhythm patients
Stark differences in access to new medicines to reduce the risk of strokes in people with the heart rhythm disorder atrial fibrillation (AF) are revealed in a new report from the Atrial Fibrillation Association. The chance of receiving the newer treatments varies 16-fold across England, the report says. In one part of England 69% of patients receive the newer treatments – in another part just 4% are prescribed them.